Based on published studies, our hypothesis is that adding recombinant Insulin to the cell growth media for suspension HEK293 cells would improve viral titre.

Novo Nordisk Pharmatech will be presenting case studies on Lentivirus and three serotypes of AAVs, where we measured the effect of adding different concentrations of Insulin Human AF at different times during viral production.